Publikationen von F. Broecker
Alle Typen
Zeitschriftenartikel (22)
21.
Zeitschriftenartikel
135 (26), S. 9713 - 9722 (2013)
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. Journal of the American Chemical Society 22.
Zeitschriftenartikel
9, 134 (2012)
Short hairpin-looped oligodeoxynucleotides reduce hepatitis C virus replication. Virology Journal Buchkapitel (2)
23.
Buchkapitel
1518, S. 227 - 240. Springer, New York (2017)
Synthetic glycan microarrays. In: Methods in Molecular Biology, Bd. 24.
Buchkapitel
Lepenies, B.). Springer Science+Business Media, New York (2015)
Generation of monoclonal antibodies against defined oligosaccharide antigens. In: Carbohydrate-Based Vaccines, S. 57 - 80 (Hg. Meeting Abstract (2)
25.
Meeting Abstract
25 (5) Supplement 1 Aufl., 728, S. 335 - 335. 20th Annual Meeting of the American Society of Gene and Cell Therapy, Washington, DC, 10. Mai 2017 - 13. Mai 2017. No longer published by Elsevier, San Diego, CA (2017)
Analysis of the AAVrh. 10 capsid structure and its antigenic and receptor interactions. In Molecular Therapy, 26.
Meeting Abstract
24 (11), S. 1129 - 1129. Joint Meeting of the Society-for-Glycobiology (SFG) and the
Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, HI, 16. November 2014 - 19. November 2014. Oxford University Press, Oxford (2014)
Deciphering glycan-antibody interactions: towards a carbohydrate-based vaccine against Clostridium difficile. In Glycobiology, Hochschulschrift - Doktorarbeit (1)
27.
Hochschulschrift - Doktorarbeit
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans. Dissertation, 155 S., Freie Universität Berlin, Berlin (2016)
Patent (2)
28.
Patent
Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
29.
Patent
Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)